230 related articles for article (PubMed ID: 34127382)
1. Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis.
Gavriilidis P; Roberts KJ; de'Angelis N; Aldrighetti L; Sutcliffe RP
Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):307-314. PubMed ID: 34127382
[TBL] [Abstract][Full Text] [Related]
2. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
Di Martino M; Rompianesi G; Mora-Guzmán I; Martín-Pérez E; Montalti R; Troisi RI
Eur J Surg Oncol; 2020 May; 46(5):772-781. PubMed ID: 31862133
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of microwave ablation versus radiofrequency ablation in the treatment of colorectal liver metastases: A systematic review and meta-analysis.
Tang Y; Zhong H; Wang Y; Wu J; Zheng J
Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102182. PubMed ID: 37479137
[TBL] [Abstract][Full Text] [Related]
5. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
Puijk RS; Ruarus AH; Vroomen LGPH; van Tilborg AAJM; Scheffer HJ; Nielsen K; de Jong MC; de Vries JJJ; Zonderhuis BM; Eker HH; Kazemier G; Verheul H; van der Meijs BB; van Dam L; Sorgedrager N; Coupé VMH; van den Tol PMP; Meijerink MR;
BMC Cancer; 2018 Aug; 18(1):821. PubMed ID: 30111304
[TBL] [Abstract][Full Text] [Related]
6. Surgical approach to microwave and radiofrequency liver ablation for hepatocellular carcinoma and colorectal liver metastases less than 5 cm: a systematic review and meta-analysis.
Abdalla M; Collings AT; Dirks R; Onkendi E; Nelson D; Ozair A; Miraflor E; Rahman F; Whiteside J; Shah MM; Ayloo S; Abou-Setta A; Sucandy I; Kchaou A; Douglas S; Polanco P; Vreeland T; Buell J; Ansari MT; Pryor AD; Slater BJ; Awad Z; Richardson W; Alseidi A; Jeyarajah DR; Ceppa E
Surg Endosc; 2023 May; 37(5):3340-3353. PubMed ID: 36542137
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases.
He N; Jin QN; Wang D; Yang YM; Liu YL; Wang GB; Tao KX
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):514-518. PubMed ID: 27465325
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
Meijerink MR; Puijk RS; van Tilborg AAJM; Henningsen KH; Fernandez LG; Neyt M; Heymans J; Frankema JS; de Jong KP; Richel DJ; Prevoo W; Vlayen J
Cardiovasc Intervent Radiol; 2018 Aug; 41(8):1189-1204. PubMed ID: 29666906
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis.
Wang LJ; Zhang ZY; Yan XL; Yang W; Yan K; Xing BC
World J Surg Oncol; 2018 Oct; 16(1):207. PubMed ID: 30322402
[TBL] [Abstract][Full Text] [Related]
10. Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
Gupta P; Maralakunte M; Kumar-M P; Chandel K; Chaluvashetty SB; Bhujade H; Kalra N; Sandhu MS
Eur Radiol; 2021 Jul; 31(7):5400-5408. PubMed ID: 33439319
[TBL] [Abstract][Full Text] [Related]
11. SAGES/AHPBA guidelines for the use of microwave and radiofrequency liver ablation for the surgical treatment of hepatocellular carcinoma or colorectal liver metastases less than 5 cm.
Ceppa EP; Collings AT; Abdalla M; Onkendi E; Nelson DW; Ozair A; Miraflor E; Rahman F; Whiteside J; Shah MM; Ayloo S; Dirks R; Kumar SS; Ansari MT; Sucandy I; Ali K; Douglas S; Polanco PM; Vreeland TJ; Buell J; Abou-Setta AM; Awad Z; Kwon CH; Martinie JB; Sbrana F; Pryor A; Slater BJ; Richardson W; Jeyarajah R; Alseidi A
Surg Endosc; 2023 Dec; 37(12):8991-9000. PubMed ID: 37957297
[TBL] [Abstract][Full Text] [Related]
12. The effect of radiofrequency ablation vs. liver resection on survival outcome of colorectal liver metastases (CRLM): a meta-analysis.
Bai H; Huangz X; Jing L; Zeng Q; Han L
Hepatogastroenterology; 2015; 62(138):373-7. PubMed ID: 25916066
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Microwave and Radiofrequency Ablation in the Treatment of Pulmonary Metastasis of Colorectal Cancer.
Tan C; Fisher OM; Huang L; Alzahrani N; Liauw W; Glenn D; Morris DL
Anticancer Res; 2022 Sep; 42(9):4563-4571. PubMed ID: 36039430
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency versus microwave ablation for intraoperative treatment of colorectal liver metastases.
Krul MF; Gerritsen SL; Vissers FL; Klompenhouwer EG; Ruers TJ; Kuhlmann KF; Kok NF
Eur J Surg Oncol; 2022 Apr; 48(4):834-840. PubMed ID: 34686404
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin.
Hompes D; Prevoo W; Ruers T
Cancer Imaging; 2011 Mar; 11(1):23-30. PubMed ID: 21435988
[TBL] [Abstract][Full Text] [Related]
16. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts.
van Tilborg AA; Scheffer HJ; de Jong MC; Vroomen LG; Nielsen K; van Kuijk C; van den Tol PM; Meijerink MR
Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1438-46. PubMed ID: 27387188
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.
Mulier S; Ruers T; Jamart J; Michel L; Marchal G; Ni Y
Dig Surg; 2008; 25(6):445-60. PubMed ID: 19212117
[TBL] [Abstract][Full Text] [Related]
18. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
[TBL] [Abstract][Full Text] [Related]
19. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.
Abdalla EK; Vauthey JN; Ellis LM; Ellis V; Pollock R; Broglio KR; Hess K; Curley SA
Ann Surg; 2004 Jun; 239(6):818-25; discussion 825-7. PubMed ID: 15166961
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for patients with multiple primarily unresectable colorectal liver metastases: a propensity matching analysis.
Liu M; Wang K; Wang Y; Bao Q; Wang H; Jin K; Liu W; Xing B
HPB (Oxford); 2021 Oct; 23(10):1586-1594. PubMed ID: 33934959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
